Computer-aided tomographic analysis of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). Correlation with pulmonary physiologic tests and patient-centred measures of perceived dyspnea and functional disability

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Salaffi, Fausto ^a   Carotti, Marina ^a   Di Donato, Eleonora ^a   Di Carlo, Marco ^a   Ceccarelli, Luca ^a   Giuseppetti, Gianmarco ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; ENZYME ANTIBODY; TOPOISOMERASE I ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREATHING; COMPUTER AIDED TOMOGRAPHIC ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CONVENTIONAL VISUAL READER BASED SCORE; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED VITAL CAPACITY; FUNCTIONAL DISEASE; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LINEAR REGRESSION ANALYSIS; LUNG FIBROSIS; LUNG FIBROSIS SCORE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MODIFIED BORG DYSPNEA INDEX; MULTIPLE REGRESSION; PATIENT CARE; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; RATING SCALE; RESPIRATORY TRACT PARAMETERS; SCORING SYSTEM; SEX RATIO; SINGLE BREATH DIFFUSING CAPACITY FOR CARBON MONOXIDE; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; UNIVARIATE ANALYSIS; VISUAL ANALOG SCALE; VISUAL READER BASED METHOD; DIAGNOSTIC IMAGING; LUNG; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PERCEPTION; PSYCHOLOGY; VITAL CAPACITY; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PERCEPTION; SCLERODERMA, SYSTEMIC; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY; YOUNG ADULT;

EID: 84961832110     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149240     Document Type: Article

References (51)

1. Steen VD, Medsger TA Jr. Changes in causes of death in systemic sclerosis.1972-2002. Ann Rheum Dis. 2007;66(7):940-944. PMID: 17329309
2. McNearney TA, Reveille JD, Fischbach M, Friedman AW, Lisse JR, Goel N, et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioural factors. Arthritis Rheum. 2007;57(2):318-326. PMID: 17330281
3. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research Group. Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum. 2009;61(8):1112-1120. doi: 10.1002/art.24676 PMID: 19644906
4. Khanna D, Nagaraja V, Tseng CH, Abtin F, Suh R, Kim G, et al. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials. Arthritis Res Ther. 2015;17(1):372. doi: 10.1186/s13075-015-0872-2 PMID: 26704522
5. Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, et al. High resolution CT findings in scleroderma-related lung diseases: findings from Scleroderma Lung Study. Chest. 2008;134(2):358-367.
6. Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron PY. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology. 1993;188(2):499-506. PMID: 8327704
7. Diot E, Boissinot E, Asquier E, Guilmot JL, Lemarié E, Valat C, et al. Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis. Chest. 1998;114(6):1623-1629 PMID: 9872198
8. Schurawitzki H, Stiglbauer R, Graninger W, Herold C, Pölzleitner D, Burghuber OC, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology. 1990;176(3):755-759. PMID: 2389033
9. Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum. 1994;37(9):1283-1289. PMID: 7945490
10. Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJRAm J Roentgenol. 1997;169(4):977-983. PMID: 9308447
11. Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol. 1991;18(10):1520-1528. PMID: 1765976
12. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Hoyles RK, Sato H, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J RespirCrit Care Med. 2008;177(11):1248-1254. doi: 10.1164/rccm.200706-877OC PMID: 18369202
13. Ooi GC, Mok MY, Tsang KW, Wong Y, Khong PL, Fung PC, et al. Interstitial lung disease in systemic sclerosis. Acta Radiol. 2003;44(3):258-264. PMID: 12751995
14. Yabuuchi H, Matsuo Y, Tsukamoto H, Horiuchi T, Sunami S, Kamitani T, et al. Evaluation of the extent of ground-glass opacity on high-resolution CT in patients with interstitial pneumonia associated with systemic sclerosis: comparison between quantitative and qualitative analysis. Clin Radiol. 2014;69(7):758-764. doi: 10.1016/j.crad.2014.03.008 PMID: 24824977
15. Kim HG, Tashkin DP, Clements PJ, Li G, Brown MS, Elashoff R, et al. A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients. Clin Exp Rheumatol. 2010;28(5 Suppl 62):26-35.
16. Shin KE, Chung MJ, Jung MP, Choe BK, Lee KS. Quantitative computed tomographic indexes in diffuse interstitial lung disease: correlation with physiologic tests and computed tomography visual scores. J Comput AssistTomogr. 2011;35(2):266-271. doi: 10.1097/RCT.0b013e31820ccf18 PMID: 21412102
17. Ariani A, Carotti M, Gutierrez M, Bichisecchi E, Grassi W, Giuseppetti GM, et al. Utility of an opensource DICOM viewer software (OsiriX) to assess pulmonary fibrosis in systemic sclerosis: preliminary results. Rheumatology International. 2014;34(4):511-516. doi: 10.1007/s00296-013-2845-6 PMID: 23949623
18. Salaffi F, Carotti M, Bosello S, Ciapetti A, Gutierrez M, Bichisecchi E, et al. Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests. BioMed Research International. 2015; doi: 10.1155/2015/834262
19. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23(5):581-590.
20. Le Roy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202-205. PMID: 3361530
21. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified RodnanTSS) in systemic sclerosis. J Rheumatol. 1995;22(7):1281-1285. PMID: 7562759
22. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-381. PMID: 7154893
23. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137-145. PMID: 7362664
24. Poole JL, Steen VD. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res. 1991;4(1):27-31. PMID: 11188583
25. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, et al. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005;52(2):592-600. PMID: 15692967
26. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, et al. Correlates of the disability index of the Health Assessment Questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum. 1999;42(11):2372-2380. PMID: 10555033
27. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, et al. The disability index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus lowdose penicillamine in systemic sclerosis trial. Arthritis Rheum. 2001;44(3):653-661. PMID: 11263780
28. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338. PMID: 16055882
29. Wegener OH, Koeppe P, Oeser PH. Measurement of lung density by computed tomography. J Computed Assist Tomograf. 1978;2(3):263-273.
30. Robinson PJ, Kreel L. Pulmonary tissue attenuation with computed tomography: comparison of inspiration and expiration scans. J Computed Assist Tomograf. 1979;3(6):740-748.
31. Rosemblum LJ, Mauceri RA, Wellenstein DE, Thomas FD, Bassano DA, Raasch BN, et al. Density pattern in the normal lung as determined by computed tomography. Radiology. 1980;137(2):409-416. PMID: 7433674
32. Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum. 2009;60(2):569-577. doi: 10.1002/art.24267 PMID: 19180517
33. Solomon JJ, Olson AL, Fischer A, Bull T, Brown KK, Raghu G. Scleroderma lung disease. Eur Respir Rev. 2013;22(127):6-19. doi: 10.1183/09059180.00005512 PMID: 23457159
34. Fujita J, Yoshinouchi T, Ohtsuki Y, Tokuda M, Yang Y, Yamadori I, et al. Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann Rheum Dis. 2001;60(3):281-283. PMID: 11171693
35. Launay D, Remy-Jardin M, Michon-Pasturel U, Mastora I, Hachulla E, Lambert M, et al. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol. 2006;33(9):1789-1801. PMID: 16960939
36. Wells AU, Rubens MB, Bois RM, Hansell DM. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol. 1993;161(6):1159-1165. PMID: 8249719
37. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006;354(25):2655-2666. PMID: 16790698
38. Roth MD, Tseng CH, Clements PJ, Furst DE, Tashkin DP, Goldin JG, et al. Scleroderma Lung Study Research Group. Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease. Arthritis Rheum. 2011;63(9):2797-2808. doi: 10.1002/art.30438 PMID: 21547897
39. Khanna D, Brown KK, Clements PJ, Elashoff R, Furst DE, Goldin J, et al. Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials. Clin Exp Rheumatol. 2010;28(2 Suppl 58):55-62.
40. Camiciottoli G, Orlandi I, Bartolucci M, Meoni E, Nacci F, Diciotti S, et al. Lung CT densitometry in systemic sclerosis, correlation with lung function, exercise test and quality of life. Chest. 2007;131(3):672-681. PMID: 17356079
41. Pu J, Roos J, Yi CA, Napel S, Rubin GD, Paik DS. Adaptive border marching algorithm: automatic lung segmentation on chest CT images. ComputMed Imaging Graph. 2008;32(6):452-462. doi: 10.1016/j. compmedimag.2008.04.005 PMID: 18515044
42. Wang J, Li F, Li Q. Automated segmentation of lungs with severe interstitial lung disease in CT. Med Phys. 2009;36(10):4592-4599. PMID: 19928090
43. Sverzellati N, Zompatori M, De Luca G, Chetta A, Bnà C, Ormitti F, et al. Evaluation of quantitative CT indexes in idiopathic interstitial pneumonitis using a low-dose technique. Eur J Radiol. 2005;56(3):370-375. PMID: 15978764
44. Hartley PG, Galvin JR, Hunninghake GW, Merchant JA, Yagla SJ, Speakmann SB, et al. High resolution CT-derived measures of lung density are valid indexes of interstitial lung disease. J Appl Physiol. 1994;76(1):271-277. PMID: 8175517
45. Patiwetwitoon S, Wangkaew S, Euathrongchit J, Kasitanon N, Louthrenoo W. High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis. J Clin Rheumatol. 2012;18(5):229-233. doi: 10.1097/RHU.0b013e318261176f PMID: 22832288
46. Clements PJ, Roth MD, Elashoff R, Tashkin DP, Goldin J, Silver RM, et al. Scleroderma Lung Study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 2007;66(12):1641-1647. PMID: 17485423
47. Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P, et al. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Ann Rheum Dis. 2014 Dec. 1. pii: annrheumdis-2014-206076. doi: 10.1136/annrheumdis-2014-206076
48. Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P. Concurrent validity of the Health Assessment Questionnaire Disability Index in Scleroderma. Arthritis Care Res. 1995;8(3):189-193. PMID: 7654804
49. Strickland G, Pauling J, Cavill C, McHugh N. Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools. Clin Rheumatol. 2012;31(8):1215-1222. doi: 10.1007/s10067-012-1997-1 PMID: 22588647
50. Volkmann ER, Tashkin DP, Li N, Furst DE, Clements P, Elashoff R. Development of a Composite Outcome Measure for Systemic Sclerosis Related Interstitial Lung Disease. Rheumatology (Sunnyvale). 2015;5:154, doi: 10.4172/2161-1149.1000154
51. Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R. Validity of the Saint George's Respiratory Questionnaire in the evaluation ofthe health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology (Oxford). 2007;46(2):296-301.